Presage Biosciences, Inc. Email Format

Biotechnology ResearchWashington, United States2-10 Employees

Presage Biosciences, Inc. is a Seattle-area biotechnology firm focused on evaluating multiple cancer drugs directly within a patient’s tumor to better predict clinical benefit. Its CIVO technology enables simultaneous testing of several anti-cancer drugs, candidates, and combinations in a single patient, aiming to reduce the high failure rate of cancer drug development by more accurately assessing efficacy in the human tumor microenvironment without typical systemic toxicities. The company positions itself in the biotechnology research industry with a Phase 0 clinical trial approach, building relationships with biopharma partners through a network of clinical sites and established collaborations with major companies. Based in Seattle, Washington, Presage emphasizes early-stage evaluation to improve drug development outcomes for cancer patients. A notable recent development involves a collaboration in a clinical trial focused on advanced skin cancer conducted with UZ Leuven and the VIB-KU Leuven Center for Cancer Biology.

Sign up for free to view info

Company overview Employee directory